Literature DB >> 26088918

Combination of 1,2,4-Oxadiazole and 1,2,5-Oxadiazole Moieties for the Generation of High-Performance Energetic Materials.

Hao Wei1,2, Chunlin He2, Jiaheng Zhang2, Jean'ne M Shreeve3.   

Abstract

Salts generated from linked 1,2,4-oxadiazole/1,2,5-oxadiazole precursors exhibit good to excellent thermal stability, density, and, in some cases, energetic performance. The design of these compounds was based on the assumption that by the combination of varying oxadiazole rings, it would be possible to profit from the positive aspects of each of the components. All of the new compounds were fully characterized by elemental analysis, IR spectroscopy, (1)H, (13)C, and (in some cases) (15)N NMR spectroscopy, and thermal analysis (DSC). The structures of 2-3 and 5-1⋅5 H2O were confirmed by single-crystal X-ray analysis. Theoretical performance calculations were carried out by using Gaussian 03 (Revision D.01). Compound 2-3, with its good density (1.85 g cm(-3)), acceptable sensitivity (14 J, 160 N), and superior detonation pressure (37.4 GPa) and velocity (9046 m s(-1)), exhibits performance properties superior to those of 1,3,5-trinitroperhydro-1,3,5-triazine (RDX).
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  X-ray diffraction; detonation properties; energetic materials; heterocycles; oxadiazoles

Year:  2015        PMID: 26088918     DOI: 10.1002/anie.201503532

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  9 in total

1.  Tautomeric-Dependent Lactam Cycloaddition with Nitrile Oxide: Facile Synthesis of 1,2,4-Oxadiazole[4,5-a]indolone Derivatives.

Authors:  Kun-Ming Jiang; Urarika Luesakul; Shu-Yue Zhao; Kun An; Nongnuj Muangsin; Nouri Neamati; Yi Jin; Jun Lin
Journal:  ACS Omega       Date:  2017-07-03

2.  New Strategy for Enhancing Energetic Properties by Regulating Trifuroxan Configuration: 3,4-Bis(3-nitrofuroxan-4-yl)furoxan.

Authors:  Lianjie Zhai; Fuqiang Bi; Yifen Luo; Naixing Wang; Junlin Zhang; Bozhou Wang
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

3.  Design of Energetic Materials Based on Asymmetric Oxadiazole.

Authors:  Xinghui Jin; Menghui Xiao; Jianhua Zhou; Guowei Zhou; Bingcheng Hu
Journal:  ChemistryOpen       Date:  2019-05-27       Impact factor: 2.911

4.  3,4-Bis(3-tetrazolylfuroxan-4-yl)furoxan: A Linear C-C Bonded Pentaheterocyclic Energetic Material with High Heat of Formation and Superior Performance.

Authors:  Lianjie Zhai; Fuqiang Bi; Junlin Zhang; Jiarong Zhang; Xiangzhi Li; Bozhou Wang; Sanping Chen
Journal:  ACS Omega       Date:  2020-05-04

5.  5-Nitrotetrazol and 1,2,4-Oxadiazole Methylene-Bridged Energetic Compounds: Synthesis, Crystal Structures and Performances.

Authors:  Jiarong Zhang; Fuqiang Bi; Zhi Yang; Qi Xue; Bozhou Wang
Journal:  Molecules       Date:  2021-11-23       Impact factor: 4.411

Review 6.  Synthetic Strategies Toward Nitrogen-Rich Energetic Compounds Via the Reaction Characteristics of Cyanofurazan/Furoxan.

Authors:  Luoluo Wang; Lianjie Zhai; Weiqing She; Minchang Wang; Junlin Zhang; Bozhou Wang
Journal:  Front Chem       Date:  2022-03-17       Impact factor: 5.221

7.  Molecule design and properties of bridged 2,2-bi(1,3,4-oxadiazole) energetic derivatives.

Authors:  Xinghui Jin; Menghui Xiao; Guowei Zhou; Jianhua Zhou; Bingcheng Hu
Journal:  RSC Adv       Date:  2019-02-12       Impact factor: 3.361

8.  High-Density Energetic Metal-Organic Frameworks Based on the 5,5'-Dinitro-2H,2'H-3,3'-bi-1,2,4-triazole.

Authors:  Yalu Dong; Panpan Peng; Baoping Hu; Hui Su; Shenghua Li; Siping Pang
Journal:  Molecules       Date:  2017-06-26       Impact factor: 4.411

9.  A Family of Energetic Materials Based on 1,2,4-Oxadiazole and 1,2,5-Oxadiazole Backbones With Low Insensitivity and Good Detonation Performance.

Authors:  Qi Xue; Fu-Qiang Bi; Jun-Lin Zhang; Zi-Jun Wang; Lian-Jie Zhai; Huan Huo; Bo-Zhou Wang; Sheng-Yong Zhang
Journal:  Front Chem       Date:  2020-02-20       Impact factor: 5.221

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.